v3.26.3
Related party transactions (Tables)
 6 Months Ended
Jun. 30, 2026
Related party transactions [abstract]  
Disclosure of key management personnel compensation
For each of the period presented, the following compensation was granted to the members of the Executive Committee of the Company and were recognized as expense:

(in thousands of euro)June 30, 2026June 30, 2025
Personnel and other short-term employee benefits1,7611,858
Extra pension benefits(50)107
Share-based compensation3461,537
Advisory fees ——
Executive Board Members and other Executive Members compensation2,0573,502
Disclosure of transactions between related parties The payments between the two companies as well as the liabilities and receivables as of June 30, 2026 are as follows:
As of June 30,2026
(in thousands of euro)PaymentsAssets/(Liabilities)
Collection (AstraZeneca to the Company) / Receivables751230
Payments (the Company to AstraZeneca) / Liabilities(39,612)
Total751(39,382)
30 juin 2026
(in thousands of euro)PaiementsBilan
Collection (Sanofi to the Company) / Receivables——
Payments (the Company to Sanofi) / Liabilities——
Total——